Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
11,898 total articles
Lovett William Radford II, a significant shareholder in Dream Finders Homes, Inc. (NASDAQ:DFH), executed two separate sales of company stock totaling approximately $2.05 million on June 11 and June 12, 2026. The transactions occurred while the stock was trading near $14.92, reflecting a substantial decline from its 52-week peak. This insider activi…
Liliana Gil Valletta, a director at Zumiez Inc. (NASDAQ:ZUMZ), executed a direct sale of 540 shares of company common stock on June 15, 2026. The transaction, valued at $10,063, occurred at a weighted average price of $18.6367 per share. Following this disposal, Valletta retains direct ownership of 5,264 shares. This insider activity coincides with…
Director Brian N. Sheth and several affiliated Haveli entities purchased approximately 1.16 million shares of Blend Labs, Inc. (NASDAQ:BLND) between June 11 and June 15, 2026, for roughly $1.99 million. The acquisitions bring the total indirect stake held by Sheth and the Haveli entities to over 18.6 million shares. The buying activity occurs as Bl…
Fractyl Health, Inc. director Ajay Royan executed an open market purchase of 23,000 shares of common stock on June 12, 2026, at a price of $0.852 per share, bringing his total direct holdings to 40,901 shares. The transaction, valued at $19,596, was disclosed via a Form 4 filing with the Securities and Exchange Commission on June 15, 2026. This acq…
Nature's Sunshine Products Inc. (NASDAQ:NATR) Executive Vice President Kevin R. Herbert executed a sale of 2,000 common shares on June 12, 2026, totaling $41,363. The transaction occurred at share prices between $20.63 and $20.75. This sale reduces Herbert's direct holdings to 48,866 shares. The transaction follows the company's Q1 2026 earnings re…
Entities affiliated with the investment firm Silver Lake, including Silver Lake Technology Investors V, L.P., have executed a sale of 546 shares of Dell Technologies Inc. (NASDAQ:DELL) Class C Common Stock on June 11, 2026. The transaction, valued at approximately $207,983, followed the conversion of an equivalent number of Class B shares into Clas…
Guardant Health, Inc. (NASDAQ:GH) Chief Information Officer Kumud Kalia executed a sale of 3,418 shares on June 11, 2026, totaling approximately $445,155. The transaction occurred at $130.24 per share, a level just below the company's 52-week high of $135. This sale takes place against a backdrop of strong recent performance, with the stock deliver…
Kim Hyong, serving as chief medical officer at Alignment Healthcare Inc. (NASDAQ: ALHC), executed the sale of 35,951 shares of common stock on June 12, 2026. The transaction, valued at approximately $713,947, was conducted under a Rule 10b5-1 trading plan established on March 13, 2026. The shares were sold at a weighted-average price of $19.8589, w…
Entities linked to Silver Lake Partners and Dell Technologies director Egon Durban executed a series of equity transactions, resulting in the sale of approximately $12.1 million in Dell Technologies Class C Common Stock. The divestment occurred against a backdrop of substantial stock appreciation and concurrent corporate financing activities. Marke…
Entities linked to Silver Lake and Dell Technologies Inc. director Egon Durban executed a sale of Dell Technologies Class C Common Stock on June 11, 2026, totaling approximately $460,495. The transaction involved the disposition of 1,209 shares, which were sold at prices ranging between $370.40 and $390.92 per share. Prior to the sale, an equivalen…
Entities affiliated with Silver Lake, including Dell Technologies Inc. (NASDAQ: DELL) board member Egon Durban, have completed the sale of a substantial block of Dell Class C Common Stock. The transactions, reported via SEC Form 4 filings on June 11, 2026, involved the disposal of 57,353 shares valued at approximately $23,728,674. This activity occ…
Joshua S. Boger, a director and significant shareholder of CervoMed Inc. (NASDAQ: CRVO), has acquired approximately $2.99 million in common stock through a private placement transaction. The acquisition, executed on June 11, 2026, involved 955,414 shares at a price of $3.14 per share. This purchase was part of a broader financing effort led by inst…
Shiv Verma, Chief Financial Officer at Robinhood Markets, Inc. (NASDAQ: HOOD), executed a sale of 3,984 shares of the company's Class A Common Stock on June 15, 2026. The transaction, valued at approximately $393,778, was conducted under a Rule 10b5-1 trading plan established on August 20, 2025. This sale occurs against a backdrop of significant re…
ContextLogic Holdings Inc. (NASDAQ: LOGC) reported a recent insider transaction involving its Chief Financial Officer and Chief Operating Officer, Stewart Scott Matthew. The executive purchased 10,000 shares of common stock on June 12, 2026, with a total transaction value of $97,600. This acquisition increases his direct ownership in the company an…
Robert C. Patent, a director at Metropolitan Bank Holding Corp. (NASDAQ: MCB), executed a sale of 10,000 shares of the company's common stock on June 12, 2026. The transaction, valued at $964,077, took place at prices ranging from $95.88 to $96.7850 per share. This divestment reduces Mr. Patent's direct holdings to 86,185 shares, a figure that incl…
Nexgel, Inc. (NASDAQ: NXGL) Chief Executive Officer and director Adam R. Levy executed a sale of common stock on June 11, 2026, offloading 3,000 shares in an open market transaction at $0.6136 per share. The transaction resulted in total proceeds of $1,840, leaving Levy with a direct holding of 333,692 shares. This insider activity unfolds against …
Molly D. Kannan, serving as the Chief Accounting Officer and Corporate Controller for Ryerson Holding Corp (NYSE:RYZ), executed a sale of 1,000 shares of the company's common equity on June 11, 2026. The transaction, valued at $30.00 per share, resulted in a total proceeds amount of $30,000. This divestment was conducted in accordance with a Rule 1…
Keith Cramer, Chief Revenue Officer at MediaAlpha, Inc. (NASDAQ: MAX), executed a sale of 13,000 shares of the company's Class A Common Stock on June 15, 2026. The transaction, valued at $123,110, was conducted at a price of $9.47 per share. This sale was facilitated through a Rule 10b5-1 trading plan, which was established specifically to cover ta…
Kontoor Brands, Inc. (NYSE: KTB) faces a pivotal moment as Executive Vice President Jennifer H. Broyles executes a significant stock sale, while the company simultaneously navigates a major strategic restructuring. The transaction occurs against a backdrop of strong quarterly earnings, a high-profile brand divestiture, and fresh analyst coverage, p…
Gevo, Inc. (NASDAQ: GEVO) Chief Financial Officer Agiri Oluwagbemileke Yusuf completed a sale of 63,028 shares on June 12, 2026, generating $88,075 in proceeds. The transaction, executed at a weighted average price of $1.3974 per share, falls within a range of $1.370 to $1.475. This divestment was conducted under a 10b5-1 trading plan established o…
American Well Corp. (NASDAQ: AMWL) director Stephen J. Schlegel sold 9,750 shares of Class A Common Stock on June 11, 2026, valued at $85,449. The sale was executed under a Rule 10b5-1 trading plan adopted in February 2026 to cover tax liabilities from the vesting and settlement of restricted stock units (RSUs) on the same day. Following the transa…
Todd C. Davis, a director at Pelthos Therapeutics Inc. (NASDAQ: PTHS), executed significant direct purchases of the company's common stock on June 11, 2026. The transactions, totaling $999,983, occurred at prices ranging from $27.63 to $28.94 per share, resulting in the acquisition of 35,948 shares. This insider activity is notable as the stock cur…
National Health Investors Inc. (NASDAQ: NHI) director Robert A. McCabe Jr. purchased 890 shares of the company's common stock on June 15, 2026, at $71.6485 per share, totaling $63,767. The transaction brings his direct holdings to 44,158.96 shares. This purchase occurs as NHI trades near its 52-week low of $67.94, with the stock currently priced at…
Gevo, Inc. (NASDAQ: GEVO) reported a recent insider transaction involving Andrew Shafer, the company's Chief Marketing, Customer, and Brand Officer, who sold 9,443 shares on June 12, 2026. The sale, valued at $13,458, was executed to satisfy tax withholding obligations linked to the vesting of a restricted stock award. This transaction occurred und…
Gevo, Inc. (NASDAQ: GEVO) Vice President of Accounting and Treasurer Gendenjamts Davaajargal executed a transaction involving the sale of 4,293 shares of the company's common stock on June 12, 2026. The divestment, valued at $6,118, was conducted at prices ranging between $1.390 and $1.475 per share. This activity occurred within a broader context …
